Literature DB >> 25270946

False dawn for cystic fibrosis disease modifiers?

David Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25270946     DOI： 10.1038/nrd4456

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients.

Authors:  Elena K Schneider; Felisa Reyes-Ortega; Jian Li; Tony Velkov
Journal:  J Vis Exp       Date:  2017-10-15       Impact factor: 1.355

Review 2.  New Therapies to Correct the Cystic Fibrosis Basic Defect.

Authors:  Christelle Bergeron; André M Cantin
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.